These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19260934)

  • 1. 'Congenital muscular dystrophy caused by integrin alpha7 deficiency'.
    Nakashima H; Kibe T; Yokochi K
    Dev Med Child Neurol; 2009 Mar; 51(3):245. PubMed ID: 19260934
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy.
    Guo C; Willem M; Werner A; Raivich G; Emerson M; Neyses L; Mayer U
    Hum Mol Genet; 2006 Mar; 15(6):989-98. PubMed ID: 16476707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
    Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
    J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital muscular dystrophy: molecular and cellular aspects.
    Jimenez-Mallebrera C; Brown SC; Sewry CA; Muntoni F
    Cell Mol Life Sci; 2005 Apr; 62(7-8):809-23. PubMed ID: 15868406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Other non-Fukuyama congenital muscular dystrophy].
    Hayashi YK
    Ryoikibetsu Shokogun Shirizu; 2001; (35):111-3. PubMed ID: 11555884
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutations in the integrin alpha7 gene cause congenital myopathy.
    Hayashi YK; Chou FL; Engvall E; Ogawa M; Matsuda C; Hirabayashi S; Yokochi K; Ziober BL; Kramer RH; Kaufman SJ; Ozawa E; Goto Y; Nonaka I; Tsukahara T; Wang JZ; Hoffman EP; Arahata K
    Nat Genet; 1998 May; 19(1):94-7. PubMed ID: 9590299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merosin negative congenital muscular dystrophy: a short report.
    Ralte AM; Sharma MC; Gulati S; Das M; Sarkar C
    Neurol India; 2003 Sep; 51(3):417-9. PubMed ID: 14652462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and etiology of congenital muscular dystrophy.
    Peat RA; Smith JM; Compton AG; Baker NL; Pace RA; Burkin DJ; Kaufman SJ; Lamandé SR; North KN
    Neurology; 2008 Jul; 71(5):312-21. PubMed ID: 18160674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAD+ biosynthesis ameliorates a zebrafish model of muscular dystrophy.
    Goody MF; Kelly MW; Reynolds CJ; Khalil A; Crawford BD; Henry CA
    PLoS Biol; 2012; 10(10):e1001409. PubMed ID: 23109907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice.
    Gawlik KI; Durbeej M
    Sci Rep; 2015 Sep; 5():13916. PubMed ID: 26355035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital muscular dystrophies: toward molecular therapeutic interventions.
    Collins J; Bönnemann CG
    Curr Neurol Neurosci Rep; 2010 Mar; 10(2):83-91. PubMed ID: 20425232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital muscular dystrophy in a new age.
    Day JW
    Neurology; 2008 Jul; 71(5):308-9. PubMed ID: 18663176
    [No Abstract]   [Full Text] [Related]  

  • 13. [Congenital muscular dystrophy (CMD)].
    Hayashi YK; Arahata K
    No To Shinkei; 1997 Apr; 49(4):311-8. PubMed ID: 9125738
    [No Abstract]   [Full Text] [Related]  

  • 14. Congenital muscular dystrophy with characteristic radiological findings similar to those with Fukuyama congenital muscular dystrophy.
    Garg A; Gulati S; Gupta V; Kalra V
    Neurol India; 2004 Dec; 52(4):496-8. PubMed ID: 15626844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fukuyama type congenital muscular dystrophy].
    Calzada-Sierra DJ
    Rev Neurol; 2002 Jan 1-15; 34(1):98. PubMed ID: 11988898
    [No Abstract]   [Full Text] [Related]  

  • 16. [Congenital muscular dystrophy with laminin-a2 deficiency in early infancy: diagnosis and long-term follow-up].
    Panteliadis C; Karatza E; Xinias I; Flaris N; Tzitiridou M; Ramantani G
    Klin Padiatr; 2005; 217(5):281-5. PubMed ID: 16167276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
    Murakami T; Nishino I
    Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD82 Is a Marker for Prospective Isolation of Human Muscle Satellite Cells and Is Linked to Muscular Dystrophies.
    Alexander MS; Rozkalne A; Colletta A; Spinazzola JM; Johnson S; Rahimov F; Meng H; Lawlor MW; Estrella E; Kunkel LM; Gussoni E
    Cell Stem Cell; 2016 Dec; 19(6):800-807. PubMed ID: 27641304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role for the alpha7beta1 integrin in vascular development and integrity.
    Flintoff-Dye NL; Welser J; Rooney J; Scowen P; Tamowski S; Hatton W; Burkin DJ
    Dev Dyn; 2005 Sep; 234(1):11-21. PubMed ID: 16003770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital muscular dystrophies and the extracellular matrix.
    Schessl J; Zou Y; Bönnemann CG
    Semin Pediatr Neurol; 2006 Jun; 13(2):80-9. PubMed ID: 17027857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.